Quest Diagnostics Incorporated: insider trading
1,858 trades by 44 directors, officers and 10% owners since 2010, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$47.4 M
41 sales by 9 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$19.8 M
17 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (44)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| Michael J. DeppeSVP, Corp. Controller & CAO | 35,203 | — | $3.1 M | |
| Patrick PlewmanSVP for Diagnostic Services | 14,684 | — | $5.0 M | |
| Catherine T. DohertyExecutive Vice President | 71,949 | — | $12.4 M | |
| Mark E. DelaneySVP & Chief Commercial Officer | 12,975 | — | $376 K | |
| Subu RamachandranSVP, Regional Businesses | 2,832 | — | — | |
| Gary M. PfeifferDirector | 29,802 | — | $292 K | |
| Karthik KuppusamySVP, Clinical Solutions | 13,619 | — | $2.2 M | |
| Robert B. CarterDirector | 3,874 | — | — | |
| Sam SamadExecutive Vice President & CFO | 33,568 | — | — | |
| Timothy L. MainDirector | 22,478 | — | — | |
| Vicky B. GreggDirector | 18,449 | — | $240 K | |
| Wright Lassiter IIIDirector | 10,329 | — | — | |
| J. E. DavisCEO and President, Director | 122,423 | — | $17.1 M | |
| Michael E. PrevoznikSVP & General Counsel | 36,557 | — | $6.6 M | |
| Denise M. MorrisonDirector | 11,929 | — | — | |
| Luis DiazDirector | 5,196 | — | — | |
| Timothy C. WentworthDirector | 1,358 | — | — | |
| Timothy M. RingDirector | 31,140 | — | — | |
| Tracey DoiDirector | 7,748 | — | — | |
| Mark A. GardnerSVP of Molecular Gen & Oncol | 4,673 | — | — | |
| Gail R. WilenskyDirector | 20,506 | — | — | |
| Stephen H. RusckowskiDirector | 389,597 | — | — | |
| Manner Carrie EglintonSVP, Advanced Diagnostics | 48,391 | — | — | |
| Mark GuinanExecutive Vice President & CFO | 98,981 | — | — | |
| Helen TorleyDirector | 6,260 | — | — | |
| Manuel O. MendezSVP & Chief Commercial Officer | 29,045 | — | — | |
| Daniel StanzioneDirector | 28,349 | — | — | |
| Everett CunninghamSVP, Commercial | 38,311 | — | — | |
| Robert A. KlugVP, Corporate Controller | 6,261 | — | — | |
| Jenne K. BritellDirector | 17,660 | — | — | |
| Jeffrey M. LeidenDirector | 6,000 | — | — | |
| Jon R. CohenSVP & Group Exec. Diag. Sol. | 31,757 | — | — | |
| John B. ZieglerDirector | 16,557 | — | — | |
| John C. BaldwinDirector | 12,949 | — | — | |
| Thomas F. BongiornoVP and Corporate Controller | 11,837 | — | — | |
| John B. HaydonSVP, Operations | 19,890 | — | — | |
| William F. BuehlerDirector | 26,225 | — | — | |
| Kathy OrdonezSVP, Diagnostic Solutions | 9,569 | — | — | |
| Robert HagemannSVP & Chief Financial Officer | 126,722 | — | — | |
| Surya N. MohapatraChairman, President & CEO, Director | 243,713 | — | — | |
| Joan Elizabeth MillerSVP-Oncology & Neurology Srvcs | 89,232 | — | — | |
| Wayne R. SimmonsVice President, Operations | 47,150 | — | — | |
| Glaxosmithkline PLCDirector, 10% owner | — | — | — | |
| Rosanne HaggertyDirector | 9,334 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Option exercise10b5-1 plan | +6,261 | $95.80 | $600 K | 41,464 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -6,261 | $260.17 | $1.6 M | 35,203 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Option exercise10b5-1 plan | +5,515 | $103.57 | $571 K | 40,718 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -5,515 | $260.17 | $1.4 M | 35,203 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Option exercise10b5-1 plan | +4,274 | $127.72 | $546 K | 19,608 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -4,274 | $257.34 | $1.1 M | 15,334 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Option exercise10b5-1 plan | +6,793 | $127.81 | $868 K | 22,127 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -6,793 | $257.34 | $1.7 M | 15,334 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -650 | $257.34 | $167 K | 14,684 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +2,615 | — | — | 12,975 | Form 4 |
| filed | Subu RamachandranSVP, Regional Businesses | Grant or award | +352 | — | — | 2,832 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Grant or award10b5-1 plan | +4,827 | — | — | 71,949 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Option exercise10b5-1 plan | +22,105 | $121.81 | $2.7 M | 94,054 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -3,818 | $245.45 | $937 K | 90,236 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -5,990 | $246.26 | $1.5 M | 84,246 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -1,151 | $246.98 | $284 K | 83,095 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,358 | $248.38 | $586 K | 80,737 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -3,004 | $249.40 | $749 K | 77,733 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,877 | $250.49 | $721 K | 74,856 | Form 4 |
| filed | Catherine T. DohertyExecutive Vice President | Sell10b5-1 plan | -2,907 | $251.24 | $730 K | 71,949 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell10b5-1 plan | -1,203 | $243.00 | $292 K | 29,802 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +25 | $235.94 | $6 K | 10,360 | Form 4 |
| filed | Timothy L. MainDirector | Small acquisition | +18 | $235.94 | $4 K | 22,478 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +41 | $235.94 | $10 K | 15,334 | Form 4 |
| filed | Wright Lassiter IIIDirector | Small acquisition | +6 | $235.96 | $1 K | 10,329 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +33 | $235.94 | $8 K | 13,619 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +63 | $235.94 | $15 K | 18,449 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +90 | $235.94 | $21 K | 33,568 | Form 4 |
| filed | Robert B. CarterDirector | Small acquisition | +10 | $235.93 | $2 K | 3,874 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $242.72 | $2.4 M | 122,423 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise10b5-1 plan | +22,677 | $112.17 | $2.5 M | 60,234 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -16,010 | $242.88 | $3.9 M | 44,224 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -6,237 | $243.63 | $1.5 M | 37,987 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -430 | $244.51 | $105 K | 37,557 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Gift10b5-1 plan | -1,000 | — | — | 36,557 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -1,600 | $235.18 | $376 K | 10,335 | Form 4 |
| filed | Timothy L. MainDirector | Small acquisition | +21 | $206.81 | $4 K | 22,460 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +102 | $206.81 | $21 K | 33,478 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +34 | $206.81 | $7 K | 11,935 | Form 4 |
| filed | Wright Lassiter IIIDirector | Small acquisition | +6 | $206.81 | $1 K | 10,323 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +37 | $206.81 | $8 K | 13,557 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +46 | $206.81 | $10 K | 15,293 | Form 4 |
| filed | Robert B. CarterDirector | Small acquisition | +11 | $206.80 | $2 K | 3,864 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +72 | $206.81 | $15 K | 18,386 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Option exercise10b5-1 plan | +3,320 | $127.73 | $424 K | 16,830 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Option exercise10b5-1 plan | +4,827 | $121.81 | $588 K | 21,657 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -8,147 | $200.00 | $1.6 M | 13,510 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $194.14 | $1.9 M | 132,423 | Form 4 |
| filed | Denise M. MorrisonDirector | Grant or award | +1,142 | — | — | 11,929 | Form 4 |
| filed | Luis DiazDirector | Grant or award | +1,142 | — | — | 5,196 | Form 4 |
| filed | Timothy M. RingDirector | Grant or award | +1,142 | — | — | 31,140 | Form 4 |
| filed | Wright Lassiter IIIDirector | Grant or award | +1,142 | — | — | 10,317 | Form 4 |
| filed | Timothy C. WentworthDirector | Grant or award | +1,142 | — | — | 1,358 | Form 4 |
| filed | Robert B. CarterDirector | Grant or award | +1,142 | — | — | 3,853 | Form 4 |
| filed | Gary M. PfeifferDirector | Grant or award | +1,142 | — | — | 31,005 | Form 4 |
| filed | Tracey DoiDirector | Grant or award | +1,142 | — | — | 7,748 | Form 4 |
| filed | Timothy L. MainDirector | Grant or award | +1,142 | — | — | 27,439 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +1,142 | — | — | 18,314 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +37 | $194.70 | $7 K | 11,901 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +39 | $194.70 | $8 K | 13,490 | Form 4 |
| filed | Wright Lassiter IIIDirector | Small acquisition | +6 | $194.70 | $1 K | 9,063 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +108 | $194.70 | $21 K | 33,376 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +68 | $194.70 | $13 K | 17,172 | Form 4 |
| filed | Robert B. CarterDirector | Small acquisition | +7 | $194.70 | $1 K | 2,711 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +49 | $194.70 | $10 K | 15,247 | Form 4 |
| filed | Timothy C. WentworthDirector | Grant or award | +215 | — | — | 215 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -3,878 | $206.21 | $800 K | 37,557 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -2,855 | $206.21 | $589 K | 15,198 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -5,558 | $206.21 | $1.1 M | 67,122 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award10b5-1 plan | +5,682 | $204.86 | $1.2 M | 20,880 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Grant or award10b5-1 plan | +7,232 | $204.86 | $1.5 M | 44,789 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +13,947 | $204.86 | $2.9 M | 40,988 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Grant or award | +51,652 | $204.86 | $10.6 M | 168,837 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +5,682 | $204.86 | $1.2 M | 14,190 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Grant or award | +1,473 | $204.86 | $302 K | 35,946 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Grant or award10b5-1 plan | +11,364 | $204.86 | $2.3 M | 78,486 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Grant or award | +6,200 | $204.86 | $1.3 M | 16,069 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -26,414 | $204.86 | $5.4 M | 142,423 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell | -2,628 | $204.86 | $538 K | 13,441 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -3,354 | $204.86 | $687 K | 41,435 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -750 | $204.86 | $154 K | 35,196 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax10b5-1 plan | -2,827 | $204.86 | $579 K | 18,053 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -7,720 | $204.86 | $1.6 M | 33,268 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -2,326 | $204.86 | $477 K | 11,864 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -5,806 | $204.86 | $1.2 M | 72,680 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -632 | $207.73 | $131 K | 67,122 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -526 | $207.73 | $109 K | 37,557 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -410 | $207.73 | $85 K | 15,198 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax10b5-1 plan | -2,968 | $204.86 | $608 K | 127,185 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -648 | $204.86 | $133 K | 67,754 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -188 | $204.86 | $39 K | 8,508 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -288 | $204.86 | $59 K | 38,083 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax10b5-1 plan | -230 | $204.86 | $47 K | 15,608 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -88 | $204.86 | $18 K | 34,473 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -869 | $204.86 | $178 K | 27,041 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -205 | $204.86 | $42 K | 9,869 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -10,000 | $212.52 | $2.1 M | 117,185 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -1,111 | $204.83 | $228 K | 38,371 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -958 | $204.83 | $196 K | 15,838 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -1,433 | $204.83 | $294 K | 68,402 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -252 | $210.01 | $53 K | 8,173 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Grant or award | +366 | — | — | 34,742 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +1,586 | — | — | 9,116 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award10b5-1 plan | +1,952 | — | — | 17,333 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +3,965 | — | — | 29,706 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Grant or award10b5-1 plan | +2,013 | — | — | 40,130 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Grant or award | +15,857 | — | — | 136,337 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Grant or award10b5-1 plan | +2,928 | — | — | 70,996 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -855 | $210.01 | $180 K | 28,851 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -2,396 | $210.01 | $503 K | 133,941 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -205 | $210.01 | $43 K | 8,911 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax10b5-1 plan | -244 | $210.01 | $51 K | 17,089 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -301 | $210.01 | $63 K | 39,829 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -259 | $206.99 | $54 K | 7,914 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -433 | $210.01 | $91 K | 70,563 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -83 | $210.01 | $17 K | 34,659 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -3,788 | $206.99 | $784 K | 130,153 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -728 | $206.99 | $151 K | 69,835 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax10b5-1 plan | -293 | $206.99 | $61 K | 16,796 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -230 | $206.99 | $48 K | 8,681 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -1,010 | $206.99 | $209 K | 27,841 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -99 | $206.99 | $20 K | 34,560 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Grant or award | +2,135 | — | — | 10,049 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -347 | $206.99 | $72 K | 39,482 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Option exercise10b5-1 plan | +26,165 | $112.17 | $2.9 M | 94,233 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -10,573 | $205.21 | $2.2 M | 83,660 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -10,122 | $206.37 | $2.1 M | 73,538 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -3,500 | $207.08 | $725 K | 70,038 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -1,619 | $208.21 | $337 K | 68,419 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -351 | $209.10 | $73 K | 68,068 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Option exercise10b5-1 plan | +5,662 | $121.81 | $690 K | 21,043 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -5,662 | $204.00 | $1.2 M | 15,381 | Form 4 |
| filed | Wright Lassiter IIIDirector | Small acquisition | +7 | $183.51 | $1 K | 9,057 | Form 4 |
| filed | Robert B. CarterDirector | Small acquisition | +6 | $183.51 | $1 K | 2,704 | Form 4 |
| filed | Vicky B. GreggDirector | Small acquisition | +67 | $183.51 | $12 K | 17,104 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +15 | $183.51 | $3 K | 8,696 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +16 | $183.52 | $3 K | 10,065 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +69 | $183.51 | $13 K | 27,910 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award10b5-1 plan | +48 | $183.51 | $9 K | 15,381 | Form 4 |
| filed | Vicky B. GreggDirector | Sell | -1,250 | $191.76 | $240 K | 17,037 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Option exercise10b5-1 plan | +55,093 | $95.80 | $5.3 M | 175,573 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -9,342 | $191.59 | $1.8 M | 166,231 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -41,004 | $192.27 | $7.9 M | 125,227 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -4,747 | $192.97 | $916 K | 120,480 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Option exercise10b5-1 plan | +7,846 | $144.47 | $1.1 M | 15,376 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Option exercise10b5-1 plan | +100 | $143.33 | $14 K | 15,476 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -7,946 | $187.35 | $1.5 M | 7,530 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -7,143 | $175.57 | $1.3 M | 120,480 | Form 4 |
| filed | Gary M. PfeifferDirector | Sell | -1,482 | $182.40 | $270 K | 29,431 | Form 4 |
| filed | Robert B. CarterDirector | Grant or award | +6 | $189.09 | $1 K | 2,698 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +15 | $189.08 | $3 K | 7,530 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +68 | $189.08 | $13 K | 25,741 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award | +46 | $189.08 | $9 K | 15,333 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Grant or award | +15 | $189.08 | $3 K | 8,379 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +70 | $189.08 | $13 K | 18,287 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise10b5-1 plan | +227 | $103.57 | $24 K | 38,344 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -83 | $187.22 | $16 K | 38,261 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -144 | $188.66 | $27 K | 38,117 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise10b5-1 plan | +175 | $103.57 | $18 K | 38,292 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -175 | $187.02 | $33 K | 38,117 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise10b5-1 plan | +28,288 | $103.57 | $2.9 M | 66,405 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -28,288 | $187.12 | $5.3 M | 38,117 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $185.00 | $365 K | 15,269 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Option exercise10b5-1 plan | +4,532 | $112.17 | $508 K | 21,776 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -4,532 | $183.00 | $829 K | 17,244 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $180.00 | $356 K | 17,244 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -123 | $175.91 | $22 K | 8,338 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Option exercise10b5-1 plan | +3,560 | $86.63 | $308 K | 24,745 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -3,560 | $175.00 | $623 K | 21,185 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell10b5-1 plan | -1,975 | $175.00 | $346 K | 19,219 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -2,210 | $170.00 | $376 K | 8,450 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Option exercise10b5-1 plan | +3,045 | $86.63 | $264 K | 13,705 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -3,045 | $167.40 | $510 K | 10,660 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Option exercise10b5-1 plan | +5,224 | $112.17 | $586 K | 15,884 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -5,224 | $167.40 | $874 K | 10,660 | Form 4 |
| filed | Vicky B. GreggDirector | Small acquisition | +79 | $167.50 | $13 K | 18,217 | Form 4 |
| filed | Wright Lassiter IIIDirector | Small acquisition | +7 | $167.51 | $1 K | 9,044 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Small acquisition | +72 | $167.50 | $12 K | 25,673 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +17 | $167.49 | $3 K | 7,515 | Form 4 |
| filed | Robert B. CarterDirector | Small acquisition | +7 | $167.51 | $1 K | 2,692 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +27 | $167.50 | $5 K | 10,660 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +80 | $167.49 | $13 K | 21,185 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -850 | $169.01 | $144 K | 25,601 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +1,203 | — | — | 18,138 | Form 4 |
| filed | Denise M. MorrisonDirector | Grant or award | +1,203 | — | — | 10,742 | Form 4 |
| filed | Timothy M. RingDirector | Grant or award | +1,203 | — | — | 29,507 | Form 4 |
| filed | Tracey DoiDirector | Grant or award | +1,203 | — | — | 6,490 | Form 4 |
| filed | Robert B. CarterDirector | Grant or award | +1,203 | — | — | 2,685 | Form 4 |
| filed | Gary M. PfeifferDirector | Grant or award | +1,203 | — | — | 30,669 | Form 4 |
| filed | Luis DiazDirector | Grant or award | +1,203 | — | — | 4,054 | Form 4 |
| filed | Wright Lassiter IIIDirector | Grant or award | +1,203 | — | — | 9,037 | Form 4 |
| filed | Timothy L. MainDirector | Grant or award | +1,203 | — | — | 26,297 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -874 | $175.31 | $153 K | 7,498 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell10b5-1 plan | -874 | $175.72 | $154 K | 8,372 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +81 | $164.42 | $13 K | 21,087 | Form 4 |
| filed | Vicky B. GreggDirector | Grant or award | +68 | $164.42 | $11 K | 16,935 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Small acquisition | +74 | $164.42 | $12 K | 26,451 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +27 | $164.42 | $4 K | 10,612 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +25 | $164.42 | $4 K | 9,246 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell10b5-1 plan | -2,555 | $170.00 | $434 K | 10,575 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,366 | $168.03 | $398 K | 164,448 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -1,411 | $168.76 | $238 K | 163,037 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -704 | $169.63 | $119 K | 162,333 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -7,249 | $167.86 | $1.2 M | 155,084 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -4,905 | $168.72 | $828 K | 150,179 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,764 | $169.56 | $469 K | 147,415 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -6,950 | $167.86 | $1.2 M | 140,465 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -5,900 | $168.66 | $995 K | 134,565 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -2,493 | $169.57 | $423 K | 132,072 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -750 | $167.86 | $126 K | 131,322 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -584 | $168.70 | $99 K | 130,738 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -267 | $169.60 | $45 K | 130,471 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -1,493 | $167.88 | $251 K | 128,978 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -902 | $168.79 | $152 K | 128,076 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Sell10b5-1 plan | -453 | $169.63 | $77 K | 127,623 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -256 | $166.71 | $43 K | 9,221 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax | -162 | $166.71 | $27 K | 20,988 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -4,643 | $170.00 | $789 K | 38,117 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -5,370 | $174.13 | $935 K | 68,068 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +5,317 | $173.74 | $924 K | 11,300 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +13,884 | $173.74 | $2.4 M | 34,061 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -1,823 | $173.74 | $317 K | 9,477 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -716 | $175.79 | $126 K | 68,068 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Grant or award | +4,434 | $173.74 | $770 K | 14,998 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -592 | $175.79 | $104 K | 38,117 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award | +5,674 | $173.74 | $986 K | 23,430 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Grant or award | +61,917 | $173.74 | $10.8 M | 198,470 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Grant or award | +1,711 | $173.74 | $297 K | 35,232 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -7,684 | $173.74 | $1.3 M | 26,377 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax | -2,280 | $173.74 | $396 K | 21,150 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -31,656 | $173.74 | $5.5 M | 166,814 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -1,879 | $173.74 | $326 K | 13,119 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Grant or award10b5-1 plan | +10,380 | $173.74 | $1.8 M | 78,448 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -867 | $173.74 | $151 K | 34,365 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Grant or award10b5-1 plan | +8,549 | $173.74 | $1.5 M | 46,666 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -5,010 | $173.74 | $870 K | 73,438 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -3,906 | $173.74 | $679 K | 42,760 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -394 | $173.74 | $68 K | 68,784 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -992 | $173.74 | $172 K | 10,564 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -322 | $173.74 | $56 K | 38,709 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax | -106 | $173.74 | $18 K | 17,756 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -1,662 | $173.74 | $289 K | 136,553 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -1,692 | $173.74 | $294 K | 33,521 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -824 | $172.61 | $142 K | 69,178 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -528 | $172.61 | $91 K | 39,031 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Shares withheld for tax | -229 | $171.75 | $39 K | 17,853 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -214 | $171.75 | $37 K | 5,983 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -2,966 | $171.75 | $509 K | 138,215 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -88 | $171.75 | $15 K | 35,212 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -869 | $171.75 | $149 K | 20,177 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Shares withheld for tax10b5-1 plan | -455 | $171.75 | $78 K | 70,002 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -233 | $171.75 | $40 K | 11,546 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -286 | $171.75 | $49 K | 39,559 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -899 | $170.99 | $154 K | 70,457 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -604 | $170.99 | $103 K | 39,845 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Sell | -320 | $169.71 | $54 K | 18,082 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Shares withheld for tax | -242 | $169.71 | $41 K | 6,197 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Shares withheld for tax | -1,031 | $169.71 | $175 K | 21,046 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -535 | $169.71 | $91 K | 71,356 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Shares withheld for tax | -287 | $169.71 | $49 K | 11,779 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Shares withheld for tax10b5-1 plan | -374 | $169.71 | $63 K | 40,449 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Shares withheld for tax | -2,936 | $169.71 | $498 K | 141,181 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Shares withheld for tax | -99 | $169.71 | $17 K | 35,300 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Grant or award | +2,042 | — | — | 18,402 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Grant or award | +4,538 | — | — | 22,077 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Grant or award | +454 | — | — | 35,399 | Form 4 |
| filed | J. E. DavisCEO and President, Director | Grant or award | +18,149 | — | — | 144,117 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Grant or award | +2,345 | — | — | 40,823 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Grant or award | +1,815 | — | — | 6,439 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Grant or award | +3,479 | — | — | 71,891 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Grant or award | +2,269 | — | — | 12,066 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Sell | -403 | $164.30 | $66 K | 4,624 | Form 4 |
| filed | Vicky B. GreggDirector | Sell | -1,250 | $164.57 | $206 K | 16,867 | Form 4 |
| filed | Vicky B. GreggDirector | Small acquisition | +72 | $158.04 | $11 K | 18,117 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +12 | $158.03 | $2 K | 9,780 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +4 | $158.03 | $632 | 5,027 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +57 | $158.04 | $9 K | 16,345 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Small acquisition | +35 | $158.04 | $6 K | 17,539 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise10b5-1 plan | +35,146 | $86.63 | $3.0 M | 73,624 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -3,009 | $162.26 | $488 K | 70,615 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Sell10b5-1 plan | -32,137 | $163.15 | $5.2 M | 38,478 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Option exercise10b5-1 plan | +33,103 | $103.57 | $3.4 M | 101,515 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -4,803 | $162.14 | $779 K | 96,712 | Form 4 |
| filed | Catherine T. DohertyEVP, Regional Businesses | Sell10b5-1 plan | -28,300 | $163.13 | $4.6 M | 68,412 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Option exercise10b5-1 plan | +8,635 | $71.17 | $615 K | 43,576 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Option exercise10b5-1 plan | +10,120 | $66.51 | $673 K | 53,696 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,100 | $152.70 | $321 K | 51,596 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,400 | $153.98 | $370 K | 49,196 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -4,135 | $154.74 | $640 K | 45,061 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,600 | $152.71 | $397 K | 42,461 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -2,331 | $154.03 | $359 K | 40,130 | Form 4 |
| filed | Michael J. DeppeSVP, Corp. Controller & CAO | Sell10b5-1 plan | -5,189 | $154.74 | $803 K | 34,941 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Sell | -1,775 | $156.92 | $279 K | 9,734 | Form 4 |
| filed | Patrick PlewmanSVP for Diagnostic Services | Small acquisition | +60 | $149.37 | $9 K | 16,258 | Form 4 |
| filed | Mark E. DelaneySVP & Chief Commercial Officer | Small acquisition | +4 | $149.39 | $598 | 5,023 | Form 4 |
| filed | Karthik KuppusamySVP, Clinical Solutions | Small acquisition | +21 | $149.37 | $3 K | 11,509 | Form 4 |
| filed | Vicky B. GreggDirector | Small acquisition | +76 | $149.37 | $11 K | 18,045 | Form 4 |
| filed | Sam SamadExecutive Vice President & CFO | Small acquisition | +37 | $149.37 | $6 K | 17,504 | Form 4 |
| filed | Mark A. GardnerSVP of Molecular Gen & Oncol | Shares withheld for tax | -120 | $155.70 | $19 K | 4,673 | Form 4 |
| filed | Michael E. PrevoznikSVP & General Counsel | Option exercise | +32,551 | $95.80 | $3.1 M | 71,029 | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice